Fact CheckerSign in

NCT07103889Completed

Effect of Acute Exercise on Biochemical Parameters in Normal-Weight and Overweight/Obese Adolescent.

Assessment of Biochemical, Metabolic, Inflammatory, and Hematological Parameters Following Acute Exercise in Normal-Weight and Overweight/Obese Adolescent Girls.

Source: ClinicalTrials.gov · Last updated 11 Sept 2025

Brief summary (registry, in English)

The goal of this interventional clinical trial is to compare the acute physiological and biochemical responses to maximal physical exercise (Spartacus test). in two groups of adolescent girls: in normal-weight and overweight/obese adolescent. The main question it aims to answer: * Does Spartacus test significantly alter glucose metabolism and lipid profile in normal-weight and overweight/obese adolescent? * How do inflammatory markers such as C-Reactive Protein \[CRP\], Erythrocyte Sedimentation Rate \[ESR\], respond immediately after and 30 minutes following maximal effort? * Are there significant changes in liver enzymes (Aspartate Aminotransferase \[AST\], Alanine Aminotransferase \[ALT\]), muscle damage indicators (creatine kinase \[CK\], Lactate Dehydrogenase \[LDH\]), and electrolyte balance post-exercise? Participants will undergo a baseline blood draw before performing the Spartacus test , a progressive maximal exercise test. Blood samples will then be collected immediately after the test and again 30 minutes post-exercise to evaluate changes in: Glucose metabolism (fasting glucose), Lipid profile (total cholesterol, High-Density Lipoprotein \[HDL\], Low-Density Lipoprotein \[LDL\], triglycerides), Liver and muscle enzymes (Aspartate Aminotransferase \[AST\], Alanine Aminotransferase \[ALT\], Creatine kinase \[CK\], Lactate Dehydrogenase \[LDH\]), Renal function markers (creatinine, urea), Inflammatory markers (C-Reactive Protein \[CRP\], Erythrocyte Sedimentation Rate \[ESR\]), Hematological profile (complete blood count: White Blood Cells \[WBC\], Red Blood Cells \[RBC\], Hemoglobin \[Hb\], Hematocrit \[Hct\], platelets), Electrolytes (sodium, potassium, chloride), Uric acid, calcium, phosphorus, magnesium, iron.

Status (registry)
Completed
Study type
Interventional
Enrollment
35 (actual)
First submitted
18 Jul 2025
Start date
10 Aug 2025
Primary completion date
13 Aug 2025
Lead sponsor
High Institute of Sports and Physical Education of Kef
Diseases
Obesity
NCT number
NCT07103889

What you commit to

  • Study type: Interventional
  • Participants enrolled: 35
  • From 10 Aug 2025 to the primary completion date, 13 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of anti-inflammatory or hormonal medications

Other illness

  • Presence of chronic diseases (diabetes, thyroid disorders, etc.)
  • Recent infection or inflammation

Other

  • Musculoskeletal or cardiovascular contraindications to maximal exercise
  • Pregnancy

Who the study is looking for

  • Female,
  • Aged 14-18 years
  • BMI between the 5th and \<85th percentile for age (normal-weight group), or BMI ≥ 85th percentile for age (overweight/obese group)
  • No chronic illness or contraindication to exercise
  • No regular medication use
  • Written informed consent from participant and parent/legal guardian

Age in the registry: 13 years to 18 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
High Institute of Sports and Physical Education of Kef
Coordinator of this site? Confirm its status
BoulifaTunisiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.